Items per page
1 - 158 of 158
Title Published in Access level OA Policy Year Views Downloads
Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient populationBJCP. British journal of clinical pharmacology
accessLevelRestricted
2025 5 0
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic ModelingClinical pharmacokinetics
accessLevelPublic
2025 51 35
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling StudyClinical pharmacology & therapeutics
accessLevelPublic
2025 57 96
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxabanBritish journal of clinical pharmacology
accessLevelRestricted
2025 50 0
Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric PatientsTherapeutic drug monitoring
accessLevelPublic
2024 8 5
Application of Microwave-Assisted Method for Lutein Extraction from Pistachio WasteJournal of nuts
accessLevelPublic
2024 101 185
Guidance on selecting optimal steady-state tacrolimus concentrations for continuous IV perfusion : insights from physiologically based pharmacokinetic modelingPharmaceuticals
accessLevelPublic
2024 94 57
Optimization of Lutein Extraction from Pistachio Waste Using Experimental Design and Ultrasonic MethodWaste and biomass valorization
accessLevelRestricted
2024 108 0
Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotypingJournal of chromatography. B
accessLevelPublic
2024 98 99
In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation settingPharmacology research & perspectives
accessLevelPublic
2024 77 55
Practice of CYP450 genotyping and phenotyping in children in a real-life settingFrontiers in pharmacology
accessLevelPublic
2023 73 113
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic DrugsPharmaceutics
accessLevelPublic
2023 110 181
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed sideCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2023 141 153
Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktailBasic & clinical pharmacology & toxicology
accessLevelRestricted
2023 114 0
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with TramadolPharmaceuticals
accessLevelPublic
2023 63 32
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCTTransplantation and cellular therapy
accessLevelPublic
2023 85 85
Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approachJournal of personalized medicine
accessLevelPublic
2023 88 20
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocolFrontiers in pain research
accessLevelPublic
2023 122 74
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT studyCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2023 124 129
Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in HumansGenome biology and evolution
accessLevelPublic
2022 524 132
Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of DrugsFrontiers in pharmacology
accessLevelPublic
2022 184 118
Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and ResponsePharmaceuticals
accessLevelPublic
2022 81 20
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spotsClinical and translational science
accessLevelPublic
2022 239 142
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialClinical and translational science
accessLevelPublic
2022 148 91
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingJournal of personalized medicine
accessLevelPublic
2022 221 205
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced ActivityFrontiers in psychiatry
accessLevelPublic
2022 98 96
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patientsFrontiers in aging neuroscience
accessLevelPublic
2022 86 86
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure SimulationClinical pharmacology and therapeutics
accessLevelPublic
2022 155 143
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokineticsCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2022 267 382
Variations in the Frequencies of Polymorphisms in the CYP450s Genes in Eight Major Ethnicities of Iran: A Review of the Human DataJournal of personalized medicine
accessLevelPublic
2022 64 83
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein ActivitiesClinical pharmacology & therapeutics
accessLevelPublic
2022 174 334
Personalized Medicine : PharmacokineticsJournal of personalized medicine
accessLevelPublic
2022 69 31
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailClinical pharmacology and therapeutics
accessLevelPublic
2021 206 129
Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in MiceACS Nano
accessLevelPublic
2021 390 487
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug TherapyAnnual Review of Pharmacology and Toxicology
accessLevelRestricted
2021 449 1
Drug-drug interactions with direct oral anticoagulants: practical recommendations for cliniciansThe American journal of medicine
accessLevelRestricted
2021 162 0
Mixing Drugs and Genetics: A Complex Hemorrhagic CocktailAmerican Journal of Medicine
accessLevelRestricted
2021 283 5
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingFrontiers in pharmacology
accessLevelPublic
2021 276 209
The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?Journal of personalized medicine
accessLevelPublic
2021 222 49
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activityBritish journal of pharmacology
accessLevelPublic
2021 321 134
The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitroBasic & Clinical Pharmacology & Toxicology
accessLevelRestricted
2021 229 2
Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MSJournal of chromatography. B
accessLevelPublic
2021 426 367
Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human DataJournal of personalized medicine
accessLevelPublic
2021 167 76
Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging TrendsFrontiers in pharmacology
accessLevelPublic
2021 181 186
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic studyCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2021 243 126
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMolecular Oncology
accessLevelPublic
2020 434 174
Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysisBritish Journal of Clinical Pharmacology
accessLevelPublic
2020 225 171
Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic OriginsDrug Safety
accessLevelPublic
2020 713 242
Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva CocktailClinical Pharmacology and Therapeutics
accessLevelPublic
2020 330 442
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
accessLevelRestricted
2020 252 1
Bioavailability of Vortioxetine After a Roux-en-Y Gastric BypassObesity Surgery
accessLevelRestricted
2020 262 1
Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytesJournal of Neuroscience Research
accessLevelRestricted
2020 311 2
Modern approaches for the phenotyping of cytochrome P450 enzymes in childrenExpert Review of Clinical Pharmacology
accessLevelRestricted
2020 209 1
Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in ChildrenTherapeutic Drug Monitoring
accessLevelPublic
2020 448 167
Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patientsJournal of Thrombosis and Haemostasis
accessLevelRestricted
2020 288 1
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJournal of Personalized Medicine
accessLevelPublic
2020 350 90
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva CocktailJournal of Personalized Medicine
accessLevelPublic
2019 469 203
Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approachesClinical Pharmacokinetics
accessLevelRestricted
2019 421 3
Variables of interest to predict glomerular filtration rate in preterm newborns in the first days of lifePediatric Nephrology
accessLevelRestricted
2019 388 1
Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulantsClinical Pharmacokinetics
accessLevelRestricted
2019 497 2
Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanomaBiochemical and Biophysical Research Communications
accessLevelPublic
2019 380 247
Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic StudyCurrent Analytical Chemistry
accessLevelRestricted
2019 465 1
CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver contentSurgery for Obesity and Related Diseases
accessLevelRestricted
2019 360 0
Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxinsBasic & Clinical Pharmacology & Toxicology
accessLevelRestricted
2019 466 4
Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer TreatmentIntegrative Cancer Therapies
accessLevelPublic
2019 373 118
Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactionsCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2019 405 272
Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled studyEuropean Journal of Pain
accessLevelRestricted
2019 396 2
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modelingPediatric Research
accessLevelRestricted
2019 331 2
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesClinical Pharmacokinetics
accessLevelPublic
2018 727 741
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical PerspectivesClinical Pharmacokinetics
accessLevelPublic
2018 516 724
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory SettingJournal of Clinical Psychiatry
accessLevelRestricted
2018 488 0
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp softwareBiopharmaceutics & Drug Disposition
accessLevelRestricted
2018 621 12
Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomesBasic & Clinical Pharmacology & Toxicology
accessLevelPublic
2018 509 539
Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term PerformanceTherapeutic Drug Monitoring
accessLevelPublic
2018 857 588
Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case reportEuropean Journal of Anaesthesiology
accessLevelPublic
2018 442 321
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)BMC Pharmacology & Toxicology
accessLevelPublic
2017 515 201
Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactionsClinical Pharmacology and Therapeutics
accessLevelRestricted
2017 493 5
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferasesJournal of pharmaceutical and biomedical analysis
accessLevelPublic
2017 659 696
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPharmacological research
accessLevelPublic
2017 659 172
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the futureClinical Pharmacology and Therapeutics
accessLevelRestricted
2017 592 0
The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Pharmacology
accessLevelPublic
2017 617 238
Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane TransportersBasic & clinical pharmacology & toxicology
accessLevelRestricted
2017 540 3
Plasma concentrations of transdermal fentanyl and buprenorphine in pigs (Sus scrofa domesticus)Veterinary Anaesthesia and Analgesia
accessLevelRestricted
2017 476 1
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized MedicineJournal of Pharmaceutical Sciences
2017 486 0
Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosisFree radical biology & medicine
accessLevelPublic
2016 670 261
An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposureToxicology and applied pharmacology
accessLevelRestricted
2016 638 2
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic DefectFrontiers in pharmacology
accessLevelPublic
2016 505 219
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
accessLevelPublic
2016 586 298
Detection of busulfan adducts on proteinsRCM. Rapid communications in mass spectrometry
accessLevelPublic
2016 659 190
Aspirin response: Differences in serum thromboxane B2 levels between clinical studiesPlatelets
accessLevelRestricted
2016 709 1
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approachClinical pharmacology and therapeutics
accessLevelPublic
2016 660 729
Pharmacogenomics of Oral Antithrombotic DrugsCurrent pharmaceutical design
2016 620 0
Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cellsFundamental & clinical pharmacology
accessLevelRestricted
2016 619 21
Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case StudyClinical therapeutics
accessLevelRestricted
2016 554 2
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling MethodBasic & clinical pharmacology & toxicology
accessLevelPublic
2016 675 519
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCurrent drug metabolism
accessLevelRestricted
2015 585 3
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewCurrent drug metabolism
accessLevelRestricted
2015 640 6
Augmented renal clearance, low ß-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort studyInternational journal of antimicrobial agents
accessLevelRestricted
2015 826 3
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
accessLevelRestricted
2015 622 3
Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a reviewCurrent drug metabolism
2014 652 0
Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping CocktailBasic & clinical pharmacology & toxicology
accessLevelRestricted
2014 645 4
Phenotyping of CYP450 in human liver microsomes using the cocktail approachAnalytical & bioanalytical chemistry
accessLevelRestricted
2014 533 2
Antiplatelet Therapy: Targeting the TxA2 PathwayJournal of cardiovascular translational research
accessLevelRestricted
2014 646 2
Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood SpotsClinical pharmacology and therapeutics
accessLevelPublic
2014 919 400
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityAIDS research and therapy
accessLevelPublic
2014 730 931
The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantationPharmacogenomics journal
accessLevelRestricted
2014 733 8
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic ModelCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2014 671 262
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasmaBioanalysis
accessLevelRestricted
2014 759 5
Role of paraoxonase-1 in CYP2C19 loss-of-function carriersThrombosis research
accessLevelRestricted
2014 669 0
A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologiesJournal of pharmaceutical and biomedical analysis
accessLevelRestricted
2014 570 7
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic StudyBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 639 372
Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative propertiesArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2013 661 0
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell modelBasic & clinical pharmacology & toxicology
accessLevelRestricted
2013 592 3
Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic modelThe journal of antimicrobial chemotherapy
accessLevelRestricted
2013 582 0
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteersBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 659 412
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
accessLevelPublic
2013 620 1,077
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute painPain physician
accessLevelPublic
2013 787 670
Applications of CYP450 Testing in the Clinical SettingMolecular diagnosis & therapy
accessLevelPublic
2013 764 854
Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing DrugsDrug metabolism and disposition
accessLevelPublic
2013 805 656
NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretionDiabetes
accessLevelPublic
2012 809 515
Transcriptional regulation of CYP2C19 and its role in altered enzyme activityCurrent drug metabolism
accessLevelRestricted
2012 601 0
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientAIDS
accessLevelPublic
2012 630 572
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteersChimia
accessLevelPublic
2012 798 1,136
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireviewBasic & clinical pharmacology & toxicology
accessLevelPublic
2012 648 680
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysisJournal of thrombosis and haemostasis
accessLevelRestricted
2012 614 0
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitroBritish journal of pharmacology
accessLevelRestricted
2012 587 0
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spotClinical pharmacology and therapeutics
2012 645 0
Analgesics in patients with hepatic impairment: pharmacology and clinical implicationsDrugs
accessLevelRestricted
2012 699 3
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionJournal of viral hepatitis
accessLevelRestricted
2012 658 0
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometryRCM. Rapid communications in mass spectrometry
accessLevelPublic
2012 841 832
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationBasic & clinical pharmacology & toxicology
accessLevelRestricted
2011 675 0
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patientsMetabolism, clinical and experimental
2011 685 0
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painNeuropharmacology
accessLevelPublic
2011 812 630
How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liverThe Journal of pharmacology and experimental therapeutics
accessLevelPrivate
2011 628 0
Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metaboliteJournal of pharmaceutical and biomedical analysis
accessLevelPublic
2011 738 825
Two structurally different T-type Ca2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in ratsFundamental & clinical pharmacology
accessLevelRestricted
2011 14 0
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneBritish journal of pharmacology
accessLevelRestricted
2010 869 2
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variabilityCurrent drug metabolism
2010 664 0
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyBritish journal of pharmacology
accessLevelRestricted
2010 642 1
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoproteinBasic & clinical pharmacology & toxicology
accessLevelRestricted
2009 633 2
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic studyJournal of chromatography
accessLevelRestricted
2009 558 0
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionPharmacogenomics journal
accessLevelRestricted
2009 900 0
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexoneFundamental & clinical pharmacology
accessLevelRestricted
2009 673 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteersDrug metabolism letters
2008 856 0
Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoproteinCurrent drug metabolism
accessLevelRestricted
2008 646 4
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patientsJournal of chromatography. B
accessLevelRestricted
2008 617 4
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover studyClinical therapeutics
accessLevelRestricted
2007 763 0
Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humorJournal of chromatography. B
accessLevelRestricted
2005 606 2
Codeine intoxication associated with ultrarapid CYP2D6 metabolismThe New England journal of medicine
accessLevelRestricted
2004 557 1
High performance liquid chromatography of acarbose and its metabolite on porous graphitic carbon columnJournal of separation science
accessLevelRestricted
2002 938 1
Simultaneous analysis of polyhydroxylated alkaloids by capillary electrophoresis using borate complexation and evaluation of sweeping technique for sensitivity improvementChromatographia
accessLevelRestricted
2002 644 1
Calystegine distribution in some solanaceous speciesPhytochemistry
accessLevelRestricted
2001 640 0
Capillary electrophoresis and high-performance anion exchange chromatography for monitoring caseinoglycomacropeptide sialylationJournal of pharmaceutical and biomedical analysis
accessLevelRestricted
2001 560 0
Routine o-glycan characterization in nutritional supplements--a comparison of analytical methods for the monitoring of the bovine kappa-casein macropeptide glycosylationJournal of chromatography
accessLevelRestricted
2001 621 0
Use of borate complexation for the separation of non-UV-absorbing calystegines by capillary electrophoresisJournal of chromatography
accessLevelRestricted
2000 643 0
Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detectionChemical and pharmaceutical bulletin
accessLevelRestricted
2000 566 0
Experimental design for enantioselective separation of celiprolol by capillary electrophoresis using sulfated beta-cyclodextrinElectrophoresis
accessLevelRestricted
1999 625 2
Development and validation of liquid chromatography and capillary electrophoresis methods for acarbose determination in pharmaceutical tabletsJournal of pharmaceutical and biomedical analysis
accessLevelRestricted
1998 627 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack